5:26 PM ET
8-K
Capital Raise
Aclaris Therapeutics Capital Raise of $50M
Aclaris Therapeutics entered into an underwriting agreement to sell 7,785,714 shares of common stock and pre-funded warrants for 6,500,000 shares at a price of $3.50 per share. The company expects to receive gross proceeds of approximately $50 million ($46.7 million net) to fund its operations. The offering is expected to close on October 28, 2026.
- Value
- $50M
- Counterparty
- Leerink Partners LLC